Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
September 2014, Part 3
First Anti–PD-1 Immunotherapy, Pembrolizumab, Receives Accelerated FDA Approval for Advanced Melanoma
FDA Approvals, News & Updates
Read More ›
Case Studies in Immunotherapy
By
Omid Hamid, MD
Immunotherapy
Read More ›
Immunotherapy in Colorectal Cancer: Present and Future
By
Beverly E Barton, PhD
Colorectal Cancer
Read More ›
Cytokines as Immune Adjuvants for Treating Cancer
By
Beverly E Barton, PhD
Editorial
Read More ›
Cervical Cancer: Beyond Today’s HPV Vaccine
By
Beverly E Barton, PhD
Editorial
Read More ›
2014 Oncology Pipeline Looks Impressive
By
Wayne Kuznar
Emerging Therapies
Read More ›